other

Sorror 2005 HCT-specific comorbidity index. Seventeen caller-assigned comorbidities with published weights 1, 2, or 3 (max 26). Pulmonary moderate vs severe and hepatic mild vs moderate/severe are mutually exclusive. Risk groups: 0 low, 1–2 intermediate, ≥3 high. Caller supplies the published category; magent does not interpret PFTs or echo and does not list for transplant. Not Charlson. Not a diagnosis. Not a medical device.

Kahn 2009 Villalta scale (ISTH SSC): five caller-assigned symptoms and six signs, each 0-3 (none/mild/moderate/severe), summed 0-33. Venous ulcer is a separate boolean and is not added as 15 points. PTS if score ≥5 or ulcer; bands none 0-4 (no ulcer), mild 5-9, moderate 10-14, severe if ≥15 or ulcer. magent does not examine the limb. Not CEAP, not VCSS, not Ginsberg PTS.

Morgan 1999 SCOFF questionnaire: five caller-assigned yes/no flags (make yourself sick, lost control over eating, lost more than one stone / 14 lb in 3 months, believe fat when others say thin, food dominates life), 1 point each, max 5. Screen-positive when two or more answers are affirmative (score ≥2). Deterministic published score with citation; not a diagnosis of an eating disorder and not a medical device. magent does not interview the patient or interpret individual items.

Titulaer 2011 DELTA-P for SCLC association in Lambert-Eaton myasthenic syndrome. One point each, at or within 3 months of LEMS onset: bulbar weakness (dysarthria/dysphagia/chewing/neck weakness); erectile dysfunction if male (always 0 if female); weight loss ≥5%; smoking at onset; age ≥50; Karnofsky <70. Max 6. Bands low 0-1, intermediate 2, high 3-6. Published SCLC percents for scores 0, 1, 3-6; none for score 2. Not a LEMS diagnosis, not SOX1, and not an SCLC screen.

Bello-Chavolla 2018 METS-IR: ln(2×glucose_mg_dl + triglycerides_mg_dl)×BMI / ln(HDL_mg_dl), natural log, two decimals. Supply glucose, triglycerides, and HDL each as exactly one of mg/dL or mmol/L (glucose ×18, TG ×88.57, HDL ×38.67). BMI is caller-supplied (10–80). highest_quartile_t2d is true only when METS-IR > 50.39 (derivation highest T2D-risk quartile). Not a diabetes diagnosis, not HOMA-IR/HOMA2, and not a treatment threshold.

Schaper 2004 IWGDF PEDIS: five independent grades, not a summed total. Perfusion 1-3 (no PAD; PAD without CLI; CLI). Extent 1-3 (<1; 1-3; >3 cm2). Depth 1-3 (superficial; fascia/muscle/tendon; bone/joint). Infection 1-4 (none; skin; deeper without SIRS; with SIRS). Sensation 1-2 (protective sensation present or lost). Label like 1-1-1-1-1. Caller assigns grades. Not a medical device or IWGDF treatment; magent does not measure the ulcer, diagnose PAD, or probe bone.

Rodger 2008 HERDOO2 after a first unprovoked VTE. Score 1 each for hyperpigmentation, edema, or redness in either leg; D-dimer ≥250 μg/L while on anticoagulants; BMI ≥30; age ≥65 (equality scores). Max 4. low_risk is true only for women with score ≤1. Men have no low-risk subgroup in the derivation. Not a medical device and not a duration-of-anticoagulation order.

Perry 2021 Canadian TIA Score (Table 1) for 7-day stroke or carotid revascularization after TIA. Clinical: first TIA 2, symptoms >=10 min 2, past carotid stenosis 2, antiplatelet 3, gait 1, unilateral weakness 1, vertigo -3, diastolic >=110 3, dysarthria/aphasia 1. Investigations: AF on ECG 2, infarct on CT 1, platelets >=400 2, glucose >=15 mmol/L 3. Age required, 0 points. Total -3 to 23. Bands <=3 low (0.5%), 4-8 medium (2.3%), >=9 high (5.9%). Not ABCD2. Not a diagnosis or admit order.

Mehran 2004 contrast-induced nephropathy risk score after PCI (eGFR model B). Points from hypotension, IABP, CHF, age >75, anemia, diabetes, contrast volume (1 per 100 mL), and caller eGFR. Returns integer score (max 41), risk group (low ≤5 through very_high ≥16), and development-set CIN percent. Not a CKD diagnosis; magent does not measure contrast or compute eGFR.

Hartley 2021 NIVO: consolidation, GCS ≤14, AF, and pH <7.25 score 1 each; time to acidaemia >12 h scores 2; eMRCD 1_to_4 → 0, 5a → 2, 5b → 3 (cannot score both). Returns 0–9 and Table 4 bands 0-2 / 3-4 / 5-6 / 7-9 with grouped in-hospital mortality 5.0 / 16.8 / 41.2 / 71.4%. Not HACOR, DECAF, APACHE II, or a weaning predictor. Not a medical device.

Mearin 2016 Rome IV C2 FC. rome_iv_fc is true iff last-3-months criteria with 6-month onset, at least 2 of 6 symptoms (straining, lumpy/hard stools, incomplete evacuation, anorectal obstruction, manual maneuvers, fewer than 3 SBM/week), loose stools rare without laxatives, and insufficient IBS criteria. symptom_count is 0-6. Caller assigns nine flags. magent does not examine the patient. Not a diagnosis, not Rome IV IBS, not Manning, not opioid-induced or child constipation.

Hoster 2008 simplified MIPI for advanced-stage mantle cell lymphoma: age (<50 0, 50–59 1, 60–69 2, ≥70 3), ECOG (0–1 0, 2–4 2), LDH/ULN (<0.67 0, 0.67–<1 1, 1–<1.5 2, ≥1.5 3), WBC ×10^9/L (<6.7 0, 6.7–<10 1, 10–<15 2, ≥15 3); max 11. Low 0–3, intermediate 4–5, high 6–11. Deterministic published score with citation; not a lymphoma diagnosis; not continuous MIPI; not MIPI-c. magent does not assay LDH or WBC.

Hoddes 1973 Stanford Sleepiness Scale degree 1-7 as assigned by the caller. Returns the degree, score (same as the degree), max 7, and published wording (feeling active and vital; alert; wide awake through almost in reverie; sleep onset soon). Not the Epworth Sleepiness Scale. Not a sleep-disorder diagnosis; magent does not observe the patient.

Marburg Heart Score (Bösner 2010 Table 3): five 1-point determinants (age/sex, known vascular disease, patient assumes cardiac origin, pain worse with exercise, pain not reproducible by palpation), max 5. Returns the published discrimination cut-off: positive (3-5) or negative (<=2). Primary-care chest-pain rule only; not an ED ACS rule-out, diagnosis, or admission order. magent does not interview the patient.

Johnson 2014 GALAD linear predictor from age, sex, AFP ng/mL, AFP-L3 percent, and DCP ng/mL. galad_score = -10.08 + 0.09*age + 1.67*sex + 2.34*log10(AFP) + 0.04*AFP-L3 + 1.33*log10(DCP); sex is 1 if male else 0. Returns galad_score to 2 decimals. Not an HCC diagnosis, listing protocol, probability, or Johnson 2015 ALBI. DCP is ng/mL, not mAU/mL.

Gupta 2011 Table 2 logistic probability of 30-day myocardial infarction or cardiac arrest after surgery from age, ASA class, functional status, creatinine category (normal, abnormal >1.5 mg/dL, or missing), and surgery type (hernia reference). Returns logit and estimated_probability_percent. Not a medical device, not a diagnosis, not surgical clearance, and not RCRI. Gupta 2011 publishes no low/high cutoff.

Iba 2017 SIC (Table 3; max 6). platelets_10e9_l >=150=0, <150 and >=100=1, <100=2. inr <=1.2=0, >1.2 and <=1.4=1, >1.4=2. sofa_four_items is the caller-assigned respiratory+cardiovascular+hepatic+renal SOFA sum (0-16; not coagulation, not CNS): 0=0, 1=1, >=2=2 (cap 2). sic true iff score >=4 and platelet_pts+inr_pts >=3. Not a sepsis or DIC diagnosis. Not ISTH overt DIC. Not JAAM-DIC. magent does not start anticoagulants.

McKee 1971 Framingham CHF criteria. Definite if two major, or one major plus two minor, are concurrent. Nine major and seven minor caller-assigned flags. Weight loss ≥4.5 kg in 5 days in response to treatment is dual: major if that is definite, else minor if that is definite, else unused. major_count and minor_count are the fixed flags only. Not a medical device, not an echocardiographic diagnosis, and not HFrEF or HFpEF staging.

Katz 1963 Index of Independence in Activities of Daily Living: six caller-assigned independence flags (bathing, dressing, toileting, transferring, continence, feeding). Each independent function scores 1; max 6. magent sums the published 0–6 count and does not observe the patient. Not the Barthel Index, not Katz letter grades A–G, and not a rehab order or placement decision. Not a medical device.

Mearin 2016 Rome IV IBS. rome_iv_ibs is true iff recurrent abdominal pain at least 1 day per week in the last 3 months, onset at least 6 months prior, and at least two of: related to defecation, change in stool frequency, and change in stool form. supporting_features_met is 0-3. Caller assigns five flags. magent does not examine the patient. Not a diagnosis, not Rome III, not IBS subtype.

Cadarette 2000 Osteoporosis Risk Assessment Instrument (ORAI). Additive Table 4 score: age ≥75 → 15, 65–74 → 9, 55–64 → 5, 45–54 → 0; weight <60 kg → 9, 60–69 kg → 3, ≥70 kg → 0; current estrogen no → 2, yes → 0. Max 26. Score ≥9 would be selected for bone densitometry. Age 45–120; weight_kg or weight_lb. Not a medical device, not OSTA, not FRAX, not a DXA order.

Jalan 2014 CLIF-C ACLF (CANONIC) from caller-assigned CLIF-C OF (integer 6-18), age, and WBC in 10^9/L. Score = 10 × (0.33 × CLIF-C OF + 0.04 × age + 0.63 × ln(WBC) − 2), rounded to 1 decimal then clamped 0-100. magent does not score the six organs or compute CLIF-C OF. Not MELD, MELD-Na, Child-Pugh, CLIF-SOFA, or a transplant listing protocol. Not a medical device.

Koh 2001 Osteoporosis Self-Assessment Tool for Asians (OSTA). Index = trunc(0.2 × (weight_kg − age)) toward zero. Risk low if index > −1, intermediate if −1 through −4, high if index < −4. Age 18–120; weight_kg or weight_lb. Not a medical device, not FRAX, not a DXA order. Derivation was postmenopausal Asian women.

Spyropoulos 2011 7-factor associative IMPROVE VTE score during hospitalization: previous VTE 3, known thrombophilia 2, lower-limb paralysis 2, current cancer 2, immobilized >=7 days 1, ICU/CCU stay 1, age >60 1. Max 12. Bands: 0-1; 2-3 (observed VTE 1.5%); >=4 (observed VTE 5.7%). Not a VTE diagnosis or prophylaxis order. Not the 4-factor admission predictive model. Not IMPROVEDD. magent does not examine the patient.